Published in Circ Res on February 01, 1970
Further studies on the effect of ageing on beta-adrenoceptor activity of rat aorta. Br J Pharmacol (1971) 1.21
Effects of isoprenaline and phenylephrine on energy-rich phosphate compounds and glucose-6-phosphate in smooth and cardiac muscle. Br J Pharmacol (1971) 1.13
Toward Ubiquitous Blood Pressure Monitoring via Pulse Transit Time: Theory and Practice. IEEE Trans Biomed Eng (2015) 1.06
Evidence for reduced beta-adrenoceptor coupling to adenylate cyclase in femoral arteries from spontaneously hypertensive rats. Br J Pharmacol (1988) 0.96
Thyroxine treatment of aged or young rats demonstrates that vascular responses mediated by beta-adrenoceptor subtypes can be differentially regulated. Br J Pharmacol (1986) 0.91
Age-related changes in the response of rabbit isolated aortae to vasoactive agents. Br J Pharmacol (1978) 0.90
Lymphocyte cyclic AMP production in the elderly: the effects of prostaglandin E1. Br J Clin Pharmacol (1981) 0.90
Hormesis and adaptive cellular control systems. Dose Response (2008) 0.86
Beta-adrenergic inhibition of bovine mesenteric lymphatics. J Physiol (1986) 0.85
Age-related changes in the sensitivity to verapamil and sodium nitroprusside of vascular smooth muscle of rabbit aorta. Br J Pharmacol (1985) 0.85
The response of the isolated ductus arteriosus to transmural stimulation and drugs. Br J Pharmacol (1980) 0.81
The effect of age on -adrenoceptor activity in tracheal smooth muscle. Br J Pharmacol (1973) 0.81
Aging and cholinergic responses in bovine trachealis muscle. Br J Pharmacol (1988) 0.79
Alterations with age of the response to vasodilator agents in isolated mesenteric arteries of the beagle. Br J Pharmacol (1986) 0.78
Biochemical and molecular aspects of vascular adrenergic regulation of blood pressure in the elderly. Int J Hypertens (2011) 0.75
Isoproterenol acts as a biased agonist of the alpha-1A-adrenoceptor that selectively activates the MAPK/ERK pathway. PLoS One (2015) 0.75
A simple, sensitive method for the assay of adenyl cyclase. J Pharmacol Exp Ther (1968) 8.05
Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther (1973) 5.23
Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther (1973) 4.40
Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther (1973) 3.89
Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines. J Pharmacol Exp Ther (1966) 2.75
Possible mechanism of liver necrosis caused by aromatic organic compounds. Proc Natl Acad Sci U S A (1971) 2.00
Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro. J Pharmacol Exp Ther (1973) 1.90
Interrelationships of catecholamines with other endocrine systems. Pharmacol Rev (1966) 1.89
Comparison of drug-induced responses of rabbit trachea and bronchus. J Appl Physiol (1976) 1.78
Interactions of drugs with adrenergic neurons. Pharmacol Rev (1966) 1.76
Displacement of one drug by another from carrier or receptor sites. Proc R Soc Med (1965) 1.68
The effects of inorganic ions on the storage and uptake of H3-norepinephrine by rat heart slices. J Pharmacol Exp Ther (1969) 1.55
Urate crystal induced inflammation in the rat: evidence for the combined actions of kinins, histamine and components of complement. Immunol Commun (1972) 1.42
On the measurement of vascular and respiratory smooth muscle responses in vitro. Blood Vessels (1977) 1.39
Interaction between desipramine, tyramine, and amphetamine at adrenergic neurones. Br J Pharmacol (1968) 1.38
Evidence that blockade of adrenergic receptors causes overflow of norepinephrine in cats colon after nerve stimulation. J Pharmacol Exp Ther (1967) 1.30
The role of brain serotonin in the mechanism of the central action of reserpine. J Pharmacol Exp Ther (1966) 1.30
Compulsive sexual activity induced by p-chlorophenylalanine in normal and pinealectomized male rats. Science (1969) 1.28
The physiological disposition of chlorpromazine in the rat and dog. Proc Soc Exp Biol Med (1970) 1.28
Alterations in pharmacologic receptor activity by dithiothreitol. Am J Physiol (1974) 1.25
Evidence for existence of alpha-adrenergic receptors in the mammalian trachea. Am J Physiol (1970) 1.24
Mechanisms by which diazepam, muscimol, and other drugs change the content of cGMP in cerebellar cortex. Proc Natl Acad Sci U S A (1977) 1.23
Physicochemical and biochemical aspects of pharmacology. JAMA (1967) 1.21
Further studies on the effect of ageing on beta-adrenoceptor activity of rat aorta. Br J Pharmacol (1971) 1.21
Essential role of testosterone in the sexual stimulation induced by p-chlorophenylalanine in male animals. Nature (1970) 1.17
Pharmacologic receptor activity of rabbit aorta. Effect of dithiothreitol and N-ethylmaleimide. Circ Res (1973) 1.16
On the role of adenyl cyclase in the regulation of lipolysis in fasting. Biochem Pharmacol (1969) 1.15
Effects of thyroid hormones on adenyl cyclase in adipose tissue and on free fatty acid mobilization. Proc Natl Acad Sci U S A (1968) 1.13
The effects of desmethylimipramine on uptake of dl-norepinephrine-7-H3 in the heart. J Pharmacol Exp Ther (1966) 1.12
The relationship between age and relaxation of vascular smooth muscle in the rabbit and rat. Circ Res (1976) 1.10
Mechanism of biogenic amine transport. II. Relationship between sodium and the mechanism of ouabain blockade of the accumulation of serotonin and norepinephrine by synaptosomes. Mol Pharmacol (1969) 1.10
Brain amines and temperature regulation. Pharmacology (1968) 1.10
Application of seady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma. J Pharmacol Exp Ther (1967) 1.09
Inflammation induced by histamine, serotonin, bradykinin and compound 48-80 in the rat: antagonists and mechanisms of action. J Pharmacol Exp Ther (1974) 1.09
LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist. J Pharmacol Exp Ther (1985) 1.09
Uptake and release of 3-H-histamine in cat submaxillary gland. Fed Proc (1967) 1.08
Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI. J Pharmacol Exp Ther (1999) 1.07
The prevention of isoproterenol desensitization and isoproterenol reversal. J Pharmacol Exp Ther (1972) 1.06
Role of sodium, potassium, ouabain and reserpine in uptake, storage and metabolism of biogenic amines in synaptosomes. Life Sci (1968) 1.05
LY83583: an agent that lowers intracellular levels of cyclic guanosine 3',5'-monophosphate. J Pharmacol Exp Ther (1985) 1.04
Approaches to the molecular nature of pharmacological receptors. Pharmacol Rev (1969) 1.03
Some pharmacological consequences of species variation in rates of metabolism. Fed Proc (1967) 1.02
Application of steady-state kinetics to the uptake and decline of H3-NE in the rat heart. J Pharmacol Exp Ther (1968) 1.01
Age-related changes in the sensitivity of blood vessels to drugs. Pharmacol Ther (1980) 1.01
Evidence for multiple leukotriene D4 receptors in smooth muscle. Life Sci (1982) 1.00
Theophylline as a tool in studies of the role of cyclic adenosine 3',5'-monophosphate in hormone-induced lipolysis. J Pharmacol Exp Ther (1966) 0.98
Role of sodium and potassium ions in storage of norepinephrine by sympathetic nerve endings. Life Sci (1966) 0.97
Effects of caffeine and theophylline on activity of rats in relation to brain xanthine concentrations. Proc Soc Exp Biol Med (1972) 0.96
Effect of Initial Nematode Density on Managing Globodera rostochiensis with Resistant Cultivars and Nonhosts. J Nematol (1996) 0.95
Evidence for a role of adenosine 3',5'-monophosphate in adipose tissue lipolysis. Biochem Pharmacol (1966) 0.95
The Potential of Thiarubrine C as a Nematicidal Agent against Plant- parasitic Nematodes. J Nematol (1998) 0.92
Vascular smooth muscle reactivity in normotensive and hypertensive rats. Science (1969) 0.91
Leukotriene receptor antagonists as potential therapeutic agents. Annu Rev Pharmacol Toxicol (1989) 0.90
Production and antagonism of cutaneous vascular permeability in the guinea pig in response to histamine, leukotrienes and A23187. J Pharmacol Exp Ther (1984) 0.90
Serotonin in brain: functional considerations. Adv Pharmacol (1968) 0.90
Kinetics of release of norepinephrine by tyramine. Life Sci (1965) 0.90
Behavioral and vegetative effects produced by dibutyryl cyclic AMP injected into different areas of the brain. Adv Biochem Psychopharmacol (1970) 0.89
Effects of phenylbutazone on liver microsomal demethylase. Biochem Pharmacol (1970) 0.89
Evidence that hyperthermia produced by d-amphetamine is caused by a peripheral action of the drug. Life Sci (1969) 0.88
Apparent depletion of NE stores after repetitive stimulation of cat colon in presence of phenoxybenzamine. Int J Neuropharmacol (1966) 0.88
Histofluorescent study of catecholamine-containing elements in cholinergic ganglia from the calf and dog lung. Proc Soc Exp Biol Med (1973) 0.87
Effect of local anesthetics on pharmacologic receptor systems of smooth muscle. J Pharmacol Exp Ther (1973) 0.87
Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies. J Pharmacol Exp Ther (1999) 0.87
The sympathetic nervous system as a homeostatic mechanism. I. Absolute need for sympathetic nervous function in body temperature maintenance of cold-exposed rats. J Pharmacol Exp Ther (1967) 0.87
Lipid Composition of Cyst Stages of Globodera rostochiensis. J Nematol (1995) 0.86
Effects of the second-generation leukotriene B(4) receptor antagonist, LY293111Na, on leukocyte infiltration and collagen-induced arthritis in mice. Eur J Pharmacol (2000) 0.86
On mechanisms of norepinephrine release by amphetamine and tyramine and tolerance to their effects. Adv Biochem Psychopharmacol (1969) 0.86
The effect of ganglionic agonists and antagonists on the cardiac sympathetic ganglia of the dog. J Pharmacol Exp Ther (1970) 0.85
Bromobenzene metabolism and hepatic necrosis. Pharmacology (1971) 0.85
Drug metabolism as a cause of drug toxicity. Drug Metab Dispos (1974) 0.85
ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia. Brain Res (2000) 0.84
Pharmacologic receptors for the leukotrienes. Biochem Pharmacol (1984) 0.84
The effect of norepinephrine and insulin on brown fat cell membrane potentials. Life Sci I (1970) 0.84
Enhanced hepatic microsomal activity by pretreatment of rats with acetone or isopropanol. Proc Soc Exp Biol Med (1973) 0.84
Slow reacting substance of anaphylaxis (SRS-A) release from guinea-pig lung parenchyma during antigen- or ionophore-induced contraction. J Pharmacol Exp Ther (1982) 0.84
Drug metabolism in man: past, present, and future. Ann N Y Acad Sci (1971) 0.84
Selective labeling of histamine in rat gastric mucosa: application to measurement of turnover rate. J Pharmacol Exp Ther (1968) 0.84
Nature of the protection against carbon tetrachloride-induced hepatotoxicity produced by pretreatment with dibenamine (N-(2-chloroethyl)dibenzylamine). Biochem Pharmacol (1974) 0.83
Selective labeling and release of nonmast-cell histamine. Life Sci (1966) 0.83
Biochemical mechanism of hepatic necrosis induced by aromatic hydrocarbons. Pharmacology (1973) 0.83
Serotonin-induced pulmonary responses in the perfused guinea pig lung: evidence for 5HT2 receptor-mediated pulmonary vascular and airway smooth muscle constriction. Pulm Pharmacol (1988) 0.83
Enhanced hepatotoxicity of carbon tetrachloride, thioacetamide, and dimethylnitrosamine by pretreatment of rats with ethanol and some comparisons with potentiation by isopropanol. Toxicol Appl Pharmacol (1975) 0.83
Adenyl cyclase activity of rabbit aorta. J Pharm Pharmacol (1971) 0.83
Pharmacologic analysis of two novel inhibitors of leukotriene (slow reacting substance) release. J Pharmacol Exp Ther (1984) 0.83
Mechanism of transport and storage of biogenic amines. 3. Effects of sodium and potassium on kinetics of 5-hydroxytryptamine and norepinephrine transport by rabbit synaptosomes. Biochim Biophys Acta (1970) 0.82
Schultz-Dale reaction in mouse trachea. J Pharmacol Methods (1981) 0.81
Activation of 3':5'-cyclic AMP-dependent protein kinase and induction of ornithine decarboxylase as early events in induction of mixed-function oxygenases. Proc Natl Acad Sci U S A (1976) 0.81
Evidence for the metabolism of bumetanide in man. Life Sci (1975) 0.81
The pharmacologic effects of ST-155 (Catapres) and related imidazolines in the rat. Pharmacology (1969) 0.81
Identification of RFLP markers linked to the H1 gene conferring resistance to the potato cyst nematode Globodera rostochiensis. Genome (1993) 0.80
Inhibition of antigen-induced mediator release from guinea pig lung by alcohols. Am Rev Respir Dis (1976) 0.80
Leukotriene receptor antagonists. 1. Synthesis and structure-activity relationships of alkoxyacetophenone derivatives. J Med Chem (1987) 0.80
Pharmacology of the aorta. A brief review. Blood Vessels (1974) 0.80
Evaluation of LY163443, 1-[2-hydroxy-3-propyl-4-([4- (1H-tetrazol-5-ylmethyl)phenoxy]methyl) phenyl]ethanone, as a pharmacologic antagonist of leukotrienes D4 and E4. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.79
A novel leukotriene B4-receptor antagonist in endotoxin shock: a prospective, controlled trial in a porcine model. Crit Care Med (1993) 0.79
Nicotinic and muscarinic receptors in the cardiac sympathetic ganglia of the dog. J Pharmacol Exp Ther (1969) 0.79